Latest Insider Transactions at Otonomy, Inc. (OTIC)
This section provides a real-time view of insider transactions for Otonomy, Inc. (OTIC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OTONOMY, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OTONOMY, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
David Allen Weber Director |
SELL
Payment of exercise price or tax liability
|
Direct |
91,636
-24.27%
|
$0
$0.09 P/Share
|
|
Dec 28
2022
|
Paul E Cayer President and CFBO |
SELL
Payment of exercise price or tax liability
|
Direct |
40,054
-17.9%
|
$0
$0.09 P/Share
|
|
Nov 28
2022
|
Vickie L Capps Director |
SELL
Open market or private sale
|
Direct |
42,242
-92.55%
|
$0
$0.1 P/Share
|
|
Mar 28
2022
|
Paul E Cayer President and CFBO |
SELL
Open market or private sale
|
Direct |
5,624
-2.45%
|
$11,248
$2.41 P/Share
|
|
Mar 28
2022
|
Alan Charles Foster Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,559
-1.43%
|
$5,118
$2.41 P/Share
|
|
Mar 28
2022
|
Robert Michael Savel Ii Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
3,325
-2.23%
|
$6,650
$2.41 P/Share
|
|
Mar 28
2022
|
David Allen Weber Director |
SELL
Open market or private sale
|
Direct |
11,243
-2.89%
|
$22,486
$2.41 P/Share
|
|
Mar 25
2022
|
Paul E Cayer President and CFBO |
SELL
Open market or private sale
|
Direct |
4,015
-1.72%
|
$8,030
$2.39 P/Share
|
|
Mar 25
2022
|
Alan Charles Foster Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,827
-1.01%
|
$3,654
$2.39 P/Share
|
|
Mar 25
2022
|
Robert Michael Savel Ii Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,374
-1.57%
|
$4,748
$2.39 P/Share
|
|
Mar 25
2022
|
David Allen Weber Director |
SELL
Open market or private sale
|
Direct |
8,026
-2.02%
|
$16,052
$2.39 P/Share
|
|
Jan 14
2022
|
David Allen Weber Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+27.43%
|
-
|
|
Jan 14
2022
|
Robert Michael Savel Ii Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+31.61%
|
-
|
|
Jan 14
2022
|
Alan Charles Foster Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+27.84%
|
-
|
|
Jan 14
2022
|
Paul E Cayer President and CFBO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+29.99%
|
-
|
|
Apr 16
2021
|
David Allen Weber Director |
BUY
Grant, award, or other acquisition
|
Direct |
220,000
+47.13%
|
-
|
|
Apr 16
2021
|
Paul E Cayer President and CFBO |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+45.19%
|
-
|
|
Apr 16
2021
|
Robert Michael Savel Ii Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+44.39%
|
-
|
|
Mar 03
2021
|
Jay Lichter Director |
SELL
Open market or private sale
|
Indirect |
321,180
-100.0%
|
$642,360
$2.7 P/Share
|
|
Mar 02
2021
|
Jay Lichter Director |
SELL
Open market or private sale
|
Indirect |
389,574
-54.81%
|
$779,148
$2.9 P/Share
|
|
Mar 01
2021
|
Jay Lichter Director |
SELL
Open market or private sale
|
Indirect |
173,700
-19.64%
|
$347,400
$2.86 P/Share
|
|
Feb 26
2021
|
Jay Lichter Director |
SELL
Open market or private sale
|
Indirect |
330,554
-27.21%
|
$661,108
$2.83 P/Share
|
|
Feb 25
2021
|
Jay Lichter Director |
SELL
Open market or private sale
|
Indirect |
311,100
-20.39%
|
$622,200
$2.95 P/Share
|
|
Feb 24
2021
|
Jay Lichter Director |
SELL
Open market or private sale
|
Indirect |
503,135
-24.79%
|
$1,006,270
$2.98 P/Share
|
|
Feb 23
2021
|
Jay Lichter Director |
SELL
Open market or private sale
|
Indirect |
268,118
-11.67%
|
$536,236
$2.89 P/Share
|